Increased subsequent risk of erectile dysfunction among middle and old age males with chronic osteomyelitis: a nationwide population-based cohort study

Article metrics

Subjects

Abstract

Chronic inflammation may cause endothelial dysfunction and atherosclerosis, resulting in subsequent erectile dysfunction (ED). We examined the relationship between chronic osteomyelitis, which is a chronic inflammatory disease, and ED. A retrospective cohort study was conducted using data from the National Health Insurance Research Database. After excluding patients <40 years of age, 677 male patients newly diagnosed with chronic osteomyelitis (COM) from 1 January 2000 to 31 December 2011 were identified for the study. The non-osteomyelitis comparison cohort consisted of 2706 male participants. The incidence of ED was 2.66-fold higher in the COM cohort than in the non-osteomyelitis cohort (4.01 vs 1.51 per 10 000 person-years). After adjusting for age and comorbidities of coronary heart disease, hypertension, hyperlipidemia, depression, stroke, diabetes, peripheral vascular disease, chronic kidney disease, chronic obstructive pulmonary disease and asthma, the patients with COM had a 2.82-fold risk of ED (95% confidence interval=1.44–5.56). The incidence of ED increased with that of comorbidities in both cohorts. The highest hazard ratio was in patients between 40 and 59 years of age who had COM. Our data showed, for the first time, that COM is a possible risk factor for the development of ED.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1

References

  1. 1

    Ayta IA, McKinlay JB, Krane RJ . The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50–56.

  2. 2

    Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JL . Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res 2002; 14: 422–432.

  3. 3

    NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.

  4. 4

    Waldvogel FA, Medoff G, Swartz MN . Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 1970; 282: 198–206.

  5. 5

    Chun J, Carson CC 3rd . Physician-patient dialogue and clinical evaluation of erectile dysfunction. Urol Clin North Am 2001; 28: 249–258, viii.

  6. 6

    Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Vasiliadou C, Alexopoulos N et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 2006; 27: 2640–2648.

  7. 7

    Carek PJ, Dickerson LM, Sack JL . Diagnosis and management of osteomyelitis. Am Fam Physician 2001; 63: 2413–2420.

  8. 8

    Dirschl DR, Almekinders LC . Osteomyelitis. Common causes and treatment recommendations. Drugs 1993; 45: 29–43.

  9. 9

    Lew DP, Waldvogel FA . Osteomyelitis. Lancet 2004; 364: 369–379.

  10. 10

    Lin SY, Lin CL, Tseng CH, Wang IK, Wang SM, Huang CC et al. The association between chronic osteomyelitis and increased risk of diabetes mellitus: a population-based cohort study. Eur J Clin Microbiol Infect Dis 2014; 33: 1647–1652.

  11. 11

    Hotamisligil GS . Inflammation and metabolic disorders. Nature 2006; 444: 860–867.

  12. 12

    Fullilove S, Jellis J, Hughes SP, Remick DG, Friedland JS . Local and systemic concentrations of tumour necrosis factor-alpha, interleukin-6 and interleukin-8 in bacterial osteomyelitis. Trans R Soc Trop Med Hyg 2000; 94: 221–224.

  13. 13

    Muneer A, Kalsi J, Nazareth I, Arya M . Erectile dysfunction. BMJ 2014; 348: g129.

  14. 14

    Basson R, Rees P, Wang R, Montejo AL, Incrocci L . Sexual function in chronic illness. J Sex Med 2010; 7: 374–388.

  15. 15

    Schouten BW, Bohnen AM, Dohle GR, Groeneveld FP, Willemsen S, Thomas S et al. Risk factors for deterioration of erectile function: the Krimpen study. Int J Androl 2009; 32: 166–175.

  16. 16

    Javaroni V, Neves MF . Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment. Int J Hypertens 2012; 2012: 627278.

  17. 17

    Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB . The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60: 458–465.

  18. 18

    Vrentzos GE, Paraskevas KI, Mikhailidis DP . Dyslipidemia as a risk factor for erectile dysfunction. Curr Med Chem 2007; 14: 1765–1770.

  19. 19

    Jung JH, Kam SC, Choi SM, Jae SU, Lee SH, Hyun JS . Sexual dysfunction in male stroke patients: correlation between brain lesions and sexual function. Urology 2008; 71: 99–103.

  20. 20

    Arrellano-Valdez F, Urrutia-Osorio M, Arroyo C, Soto-Vega E . A comprehensive review of urologic complications in patients with diabetes. Springerplus 2014; 3: 549.

  21. 21

    Suzuki E, Nishimatsu H, Oba S, Takahashi M, Homma Y . Chronic kidney disease and erectile dysfunction. World J Nephrol 2014; 3: 220–229.

  22. 22

    Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B . Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 1996; 64: 2371–2380.

  23. 23

    Ciampolini J, Harding KG . Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad Med J 2000; 76: 479–483.

  24. 24

    Hsiao LC, Muo CH, Chen YC, Chou CY, Tseng CH, Chang KC . Increased risk of coronary heart disease in patients with chronic osteomyelitis: a population-based study in a cohort of 23 million. Heart 2014; 100: 1450–1454.

  25. 25

    Tseng CH, Chen JH, Muo CH, Chang YJ, Sung FC, Hsu CY . Increased risk of ischaemic stroke amongst patients with chronic osteomyelitis: a population-based cohort study in Taiwan. Eur J Neurol 2014; 22: 633–639.

  26. 26

    de Groot L, Posthumus MD, Kallenberg CG, Bijl M . Risk factors and early detection of atherosclerosis in rheumatoid arthritis. Eur J Clin Invest 2010; 40: 835–842.

  27. 27

    Patel RV, Shelling ML, Prodanovich S, Federman DG, Kirsner RS . Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med 2011; 26: 1036–1049.

  28. 28

    Tonetti MS . Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol 2009; 36: 15–19.

  29. 29

    Stein RA . Endothelial dysfunction, erectile dysfunction, and coronary heart disease: the pathophysiologic and clinical linkage. Rev Urol 2003; 5 (Suppl 7): S21–S27.

Download references

Acknowledgements

This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan, and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding was received for this study.

Author contributions

Conception and design: Hsin-Yi Wang, Chih-Hao Chao and Chia-Hung Kao. Administrative support: Chia-Hung Kao. Data collection and assembly, data analysis and interpretation, manuscript writing and final approval of manuscript: all authors. The guarantor of the paper Chia-Hung Kao assumes responsibility for the integrity of the work as a whole.

Author information

Correspondence to C-H Kao.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading